Published June 3, 2014 | Version v1
Patent Open

Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors

Description

A novel group of gastrokines called Gastric Antrum Mucosal Protein is characterized. A member of the group is designated AMP-18. AMP-18 genomic DNA, cDNA and the AMP-18 protein are sequenced for human, mouse and pig. The AMP-18 protein and active peptides derived from it are cellular growth factors. Surprisingly, peptides capable of inhibiting the effects of the complete protein, are also derived from the AMP-18 protein. Cytoprotection and control of mammalian gastro-intestinal tissue growth and repair (restitution) is facilitated by the use of the proteins, making the proteins candidates for therapies in inflammatory bowel disease, mucositis, and gastric ulcers.

Files

US8741838.pdf

Files (3.1 MB)

Name Size Download all
md5:ce4662688eaf31902de933ab213f8c2c
3.1 MB Preview Download

Additional details

Identifiers

Patent number
US 201113042958 A
Patent application number
US 8741838 B2
Other
oai:uchicago.tind.io:9533

Dates

Patent filed
2011-03-08

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Molecular Genetics and Cell Biology, Medicine